Sanofi Aventis Groupe
- A10 - Antidiabéticos
- INSULINA LISPRO SANOFI PREFILLED PEN suspension for injection 300 IU/3 ml
- INSULINA LISPRO SANOFI suspension for injection 300 IU/3 ml
- B01 - Agentes antitrombóticos
- DUOPLAVIN film-coated tablet 75 mg+100 mg
- DUOPLAVIN film-coated tablet 75 mg+75 mg
- ISCOVER film-coated tablet 75 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- KARVEA film-coated tablet 150 mg
- KARVEA film-coated tablet 300 mg
- KARVEA film-coated tablet 75 mg
- KARVEA tablet 150 mg
- KARVEA tablet 300 mg
- KARVEA tablet 75 mg
- KARVEZIDE film-coated tablet 300 mg+12.5 mg
- KARVEZIDE film-coated tablet 300 mg+25 mg
- KARVEZIDE tablet 150 mg+12.5 mg
- KARVEZIDE tablet 300 mg+12.5 mg
- C10 - Agentes modificadores de los lípidos
- PRALUENT PREFILLED PEN solution for injection 150 mg/1 ml
- PRALUENT PREFILLED SYRINGE solution for injection 150 mg/1 ml
- PRALUENT PREFILLED SYRINGE solution for injection 300 mg/2 ml
- D11 - Otros preparados dermatológicos
- DUPIXENT PREFILLED SYRINGE solution for injection 200 mg/1 ml
- DUPIXENT PREFILLED SYRINGE solution for injection 300 mg/2 ml
- L01 - Antineoplásicos
- SARCLISA concentrate for solution for infusion 100 mg/5 ml
- SARCLISA concentrate for solution for infusion 500 mg/25 ml
- L04 - Inmunosupresores
- KEVZARA solution for injection 150 mg
- KEVZARA solution for injection 200 mg